These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 16816386)
1. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. Chen X; Kokkotou EG; Mustafa N; Bhaskar KR; Sougioultzis S; O'Brien M; Pothoulakis C; Kelly CP J Biol Chem; 2006 Aug; 281(34):24449-54. PubMed ID: 16816386 [TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230 [TBL] [Abstract][Full Text] [Related]
3. Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A. Lee JY; Park HR; Oh YK; Kim YJ; Youn J; Han JS; Kim JM J Mol Med (Berl); 2007 Dec; 85(12):1393-404. PubMed ID: 17639289 [TBL] [Abstract][Full Text] [Related]
4. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. Warny M; Keates AC; Keates S; Castagliuolo I; Zacks JK; Aboudola S; Qamar A; Pothoulakis C; LaMont JT; Kelly CP J Clin Invest; 2000 Apr; 105(8):1147-56. PubMed ID: 10772660 [TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056 [TBL] [Abstract][Full Text] [Related]
6. CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritis. Keates AC; Castagliuolo I; Qiu B; Nikulasson S; Sengupta A; Pothoulakis C Am J Physiol; 1998 Jan; 274(1):G196-202. PubMed ID: 9458790 [TBL] [Abstract][Full Text] [Related]
7. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. Chen X; Yang G; Song JH; Xu H; Li D; Goldsmith J; Zeng H; Parsons-Wingerter PA; Reinecker HC; Kelly CP PLoS One; 2013; 8(5):e64227. PubMed ID: 23675530 [TBL] [Abstract][Full Text] [Related]
8. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum. Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583 [TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile toxin A inhibits the kinase activity of extracellular signal-related kinases 1 and 2 through direct binding. Seok H; Nam HJ; Nam ST; Kang JK; Kim SK; Chang JS; Ha EM; Park YJ; Kim H J Microbiol Biotechnol; 2012 Feb; 22(2):170-5. PubMed ID: 22370345 [TBL] [Abstract][Full Text] [Related]
10. Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats. Castagliuolo I; Karalis K; Valenick L; Pasha A; Nikulasson S; Wlk M; Pothoulakis C Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G539-45. PubMed ID: 11254479 [TBL] [Abstract][Full Text] [Related]
11. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Pothoulakis C; Kelly CP; Joshi MA; Gao N; O'Keane CJ; Castagliuolo I; Lamont JT Gastroenterology; 1993 Apr; 104(4):1108-15. PubMed ID: 8462799 [TBL] [Abstract][Full Text] [Related]
12. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Qamar A; Aboudola S; Warny M; Michetti P; Pothoulakis C; LaMont JT; Kelly CP Infect Immun; 2001 Apr; 69(4):2762-5. PubMed ID: 11254650 [TBL] [Abstract][Full Text] [Related]
13. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Sougioultzis S; Simeonidis S; Bhaskar KR; Chen X; Anton PM; Keates S; Pothoulakis C; Kelly CP Biochem Biophys Res Commun; 2006 Apr; 343(1):69-76. PubMed ID: 16529714 [TBL] [Abstract][Full Text] [Related]
14. Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in mouse digestive tract. Corthier G; Lucas F; Jouvert S; Castex F Toxicon; 1992 Dec; 30(12):1583-9. PubMed ID: 1488767 [TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Castagliuolo I; LaMont JT; Nikulasson ST; Pothoulakis C Infect Immun; 1996 Dec; 64(12):5225-32. PubMed ID: 8945570 [TBL] [Abstract][Full Text] [Related]
16. Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression. Inui M; Ishida Y; Kimura A; Kuninaka Y; Mukaida N; Kondo T J Immunol; 2011 Jan; 186(1):423-31. PubMed ID: 21131421 [TBL] [Abstract][Full Text] [Related]
17. Role of the haem oxygenase/carbon monoxide pathway in Clostridium difficile toxin A-induced enteritis in mice. Medeiros CA; Warren CA; Freire R; Vieira CA; Lima BB; Vale ML; Ribeiro RA; Souza MH; Brito GA J Med Microbiol; 2011 Aug; 60(Pt 8):1146-1154. PubMed ID: 21372182 [TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for Bacteroides fragilis enterotoxin-induced enteritis. Kim JM; Jung HY; Lee JY; Youn J; Lee CH; Kim KH Eur J Immunol; 2005 Sep; 35(9):2648-57. PubMed ID: 16114110 [TBL] [Abstract][Full Text] [Related]